PetMed Express (NASDAQ:PETS) Raised to Buy at StockNews.com

StockNews.com upgraded shares of PetMed Express (NASDAQ:PETS - Free Report) from a hold rating to a buy rating in a report issued on Tuesday morning.

PetMed Express Trading Up 1.6 %

PetMed Express stock traded up $0.05 during mid-day trading on Tuesday, reaching $3.09. The company's stock had a trading volume of 146,410 shares, compared to its average volume of 299,497. PetMed Express has a twelve month low of $2.90 and a twelve month high of $6.85. The business has a 50 day moving average price of $3.91 and a 200-day moving average price of $4.49. The firm has a market cap of $63.83 million, a price-to-earnings ratio of 309.31 and a beta of 0.99.

PetMed Express (NASDAQ:PETS - Get Free Report) last announced its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.02). PetMed Express had a net margin of 0.14% and a return on equity of 0.37%. On average, equities analysts expect that PetMed Express will post 0.19 EPS for the current fiscal year.

Institutional Investors Weigh In On PetMed Express

Several large investors have recently made changes to their positions in PETS. Arrowstreet Capital Limited Partnership increased its position in PetMed Express by 26.5% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 513,381 shares of the company's stock valued at $2,474,000 after acquiring an additional 107,614 shares during the period. Metavasi Capital LP raised its stake in shares of PetMed Express by 48.5% during the fourth quarter. Metavasi Capital LP now owns 340,302 shares of the company's stock valued at $1,640,000 after purchasing an additional 111,194 shares in the last quarter. Geode Capital Management LLC lifted its holdings in PetMed Express by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 224,788 shares of the company's stock worth $1,084,000 after purchasing an additional 3,558 shares during the period. Dimensional Fund Advisors LP grew its position in PetMed Express by 2.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 216,812 shares of the company's stock valued at $1,045,000 after buying an additional 4,410 shares in the last quarter. Finally, Man Group plc increased its stake in PetMed Express by 5.5% during the 4th quarter. Man Group plc now owns 145,796 shares of the company's stock valued at $703,000 after buying an additional 7,646 shares during the period. Institutional investors and hedge funds own 73.33% of the company's stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.